TV News LIES

Thursday, Jul 17th

Last update07:24:00 AM GMT

You are here News Health FDA Approves Second Trial of Stem-Cell Therapy

FDA Approves Second Trial of Stem-Cell Therapy

E-mail Print PDF

Stem cell therapyFor only the second time, the Food and Drug Administration approved a company's request to test an embryonic stem cell-based therapy on human patients. Advanced Cell Technology (ACT), based in Marlborough, Mass., will begin testing its retinal cell treatment this year in a dozen patients with Stargardt's macular dystrophy, an inherited degenerative eye disease that leads to blindness in children. In July, the FDA released its hold on the first trial of an embryonic stem cell based treatment, for spinal cord injury.

ACT's trial will involve injecting retinal pigment epithelium (RPE) cells, which nurture the retina, into volunteers with the most advanced forms of Stargardt's, in an attempt to replace dying and no longer functioning photoreceptor cells. In animals, the infusion of healthy cells improved vision and rescued the function of some diseased cells.

Robert Lanza, ACT's chief scientific officer, is hoping that the company's RPE cells do the same in the patients, since the approval has been a long time coming. The company had initially submitted its request to begin human trials with its RPE cells in November 2009, but has spent the past year addressing the FDA's concerns about the safety of the embryonic stem from which the RPE cells are made.

The protocol involves injecting 50,000 to 100,000 RPE cells into the vitreous cavity of the eye. Because this region is protected from the body's ever-vigilant immune system, the new RPE cells do not have to be immunologically matched to the patients. But since they are made from embryonic stem cells, which can go on to become any of the body's various tissue types as well as form a type of tumor, the FDA was concerned that some pure stem cells would remain in the transplanted RPE population. Lanza says the company's scientists have developed an assay that can detect a single such stem cell from about one million RPE cells, a measure that satisfied the agency and may become a standard for future embryonic stem cell based treatments.

More...


Most Recent Related Stories...


Half of New Orleans clergy abuse claims could be tossed in US bankruptcy court

St. Louis CathedralAs New Orleans’s bankrupt Roman Catholic archdiocese finalizes a plan to settle 633 clergy abuse claims...

Dr. Oz Gets Core Tenet Of Medicaid Wrong In Fox Interview

Oz ignorantDr. Mehmet Oz, the current Medicare and Medicaid Services administrator, doesn’t seem to know who actually...

‘Maybe We Ought to Look at This System’: Senate Hearing on Vaccine Injuries Sparks Talk of Reforms

Senate hearing on vaccines Sen. Richard Blumenthal (D-Conn.), a staunch vaccine supporter, said he was “heartbroken” after hearing parents recount...

RFK Jr. and ice cream makers say they're churning up healthier ice cream

Dyes to be removedA group of ice cream makers that produce 90% of the nation’s ice cream and frozen...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!